SCOPUS 정보 검색 플랫폼

Alzheimer's and Dementia

Volumn 9, Issue 3, 2013, Pages 356-359.e1

Risk disclosure and preclinical Alzheimer's disease clinical trial enrollment

(4) Grill, Joshua D a,b Karlawish, Jason c,d Elashoff, David a,b Vickrey, Barbara G b,e

a UNIVERSITY OF CALIFORNIA (United States)

b UNIVERSITY OF CALIFORNIA (United States)

c UNIVERSITY OF PENNSYLVANIA (United States)

d UNIVERSITY OF PENNSYLVANIA (United States)

e VA GREATER LOS ANGELES HEALTHCARE SYSTEM (United States)

Author keywords

Alzheimer's disease; Clinical trial; Preclinical; Predementia; Prevention; Recruitment; Risk

Indexed keywords

ADULT; AGED; ALTRUISM; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; DECISION MAKING; FEAR; FEMALE; HUMAN; INTERVIEW; LONGITUDINAL STUDY; MALE; NORMAL HUMAN; PREVENTION STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPONSE VARIABLE; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION DISORDERS; DEMENTIA; DISCLOSURE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOTIVATION; PATIENT PARTICIPATION; PATIENT SELECTION; PREVALENCE; RISK FACTORS;

EID: 84876942135 PISSN: 15525260 EISSN: 15525279 Source Type: Journal
DOI: 10.1016/j.jalz.2012.03.001 Document Type: Article

Times cited : (29)

References (14)

1
- 79956098248
- Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- R.A. Sperling, P.S. Aisen, L.A. Beckett, D.A. Bennett, S. Craft, and A.M. Fagan Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 280 292
- (2011) Alzheimers Dement , vol.7 , pp. 280-292
- Sperling, R.A.¹ Aisen, P.S.² Beckett, L.A.³ Bennett, D.A.⁴ Craft, S.⁵ Fagan, A.M.⁶

2
- 79956084514
- The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- M.S. Albert, S.T. DeKosky, D. Dickson, B. Dubois, H.H. Feldman, and N.C. Fox The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 270 279
- (2011) Alzheimers Dement , vol.7 , pp. 270-279
- Albert, M.S.¹ Dekosky, S.T.² Dickson, D.³ Dubois, B.⁴ Feldman, H.H.⁵ Fox, N.C.⁶

3
- 67849121302
- Racial differences in patient expectations prior to resective epilepsy surgery
- C.B. Baca, E.M. Cheng, S.S. Spencer, S. Vassar, and B.G. Vickrey Racial differences in patient expectations prior to resective epilepsy surgery Epilepsy Behav 15 2009 452 455
- (2009) Epilepsy Behav , vol.15 , pp. 452-455
- Baca, C.B.¹ Cheng, E.M.² Spencer, S.S.³ Vassar, S.⁴ Vickrey, B.G.⁵

4
- 84993748524
- Techniques to identify themes
- G.W. Ryan, and H.R. Bernard Techniques to identify themes Field Methods 15 2003 85 109
- (2003) Field Methods , vol.15 , pp. 85-109
- Ryan, G.W.¹ Bernard, H.R.²

5
- 78650728457
- Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials
- J.D. Grill, and J. Karlawish Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials Alzheimers Res Ther 2 2010 34
- (2010) Alzheimers Res Ther , vol.2 , pp. 34
- Grill, J.D.¹ Karlawish, J.²

6
- 67650925282
- Disclosure of APOE genotype for risk of Alzheimer's disease
- R.C. Green, J.S. Roberts, L.A. Cupples, N.R. Relkin, P.J. Whitehouse, and T. Brown Disclosure of APOE genotype for risk of Alzheimer's disease N Engl J Med 361 2009 245 254
- (2009) N Engl J Med , vol.361 , pp. 245-254
- Green, R.C.¹ Roberts, J.S.² Cupples, L.A.³ Relkin, N.R.⁴ Whitehouse, P.J.⁵ Brown, T.⁶

7
- 40749095927
- Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study
- S. Chao, J.S. Roberts, T.M. Marteau, R. Silliman, L.A. Cupples, and R.C. Green Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study Alzheimer Dis Assoc Disord 22 2008 94 97
- (2008) Alzheimer Dis Assoc Disord , vol.22 , pp. 94-97
- Chao, S.¹ Roberts, J.S.² Marteau, T.M.³ Silliman, R.⁴ Cupples, L.A.⁵ Green, R.C.⁶

8
- 77951953129
- Effect of Alzheimer disease genetic risk disclosure on dietary supplement use
- J.A. Vernarelli, J.S. Roberts, S. Hiraki, C.A. Chen, L.A. Cupples, and R.C. Green Effect of Alzheimer disease genetic risk disclosure on dietary supplement use Am J Clin Nutr 91 2010 1402 1407
- (2010) Am J Clin Nutr , vol.91 , pp. 1402-1407
- Vernarelli, J.A.¹ Roberts, J.S.² Hiraki, S.³ Chen, C.A.⁴ Cupples, L.A.⁵ Green, R.C.⁶

9
- 0024347981
- Assessment of genetic risk for Alzheimer's disease among first-degree relatives
- L.A. Farrer, D.M. O'Sullivan, L.A. Cupples, J.H. Growdon, and R.H. Myers Assessment of genetic risk for Alzheimer's disease among first-degree relatives Ann Neurol 25 1989 485 493
- (1989) Ann Neurol , vol.25 , pp. 485-493
- Farrer, L.A.¹ O'Sullivan, D.M.² Cupples, L.A.³ Growdon, J.H.⁴ Myers, R.H.⁵

10
- 0027194791
- Gene dose of apolipoprotein e type 4 allele and the risk of Alzheimer's disease in late onset families
- E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines, and M.A. Pericak-Vance Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923
- (1993) Science , vol.261 , pp. 921-923
- Corder, E.H.¹ Saunders, A.M.² Strittmatter, W.J.³ Schmechel, D.E.⁴ Gaskell, P.C.⁵ Small, G.W.⁶ Roses, A.D.⁷ Haines, J.L.⁸ Pericak-Vance, M.A.⁹

11
- 70349558522
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
- D. Harold, R. Abraham, P. Hollingworth, R. Sims, A. Gerrish, and M.L. Hamshere Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease Nat Genet 41 2009 1088 1093
- (2009) Nat Genet , vol.41 , pp. 1088-1093
- Harold, D.¹ Abraham, R.² Hollingworth, P.³ Sims, R.⁴ Gerrish, A.⁵ Hamshere, M.L.⁶

12
- 77957138140
- A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease
- A.D. Roses, M.W. Lutz, H. Amrine-Madsen, A.M. Saunders, D.G. Crenshaw, S.S. Sundseth, M.J. Huentelman, K.A. Welsh-Bohmer, and E.M. Reiman A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease Pharmacogenomics J 10 2009 375 384
- (2009) Pharmacogenomics J , vol.10 , pp. 375-384
- Roses, A.D.¹ Lutz, M.W.² Amrine-Madsen, H.³ Saunders, A.M.⁴ Crenshaw, D.G.⁵ Sundseth, S.S.⁶ Huentelman, M.J.⁷ Welsh-Bohmer, K.A.⁸ Reiman, E.M.⁹

13
- 73549092137
- Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease
- J.C. Morris, C.M. Roe, E.A. Grant, D. Head, M. Storandt, A.M. Goate, A.M. Fagan, D.M. Holtzman, and M.A. Mintun Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease Arch Neurol 66 2009 1469 1475
- (2009) Arch Neurol , vol.66 , pp. 1469-1475
- Morris, J.C.¹ Roe, C.M.² Grant, E.A.³ Head, D.⁴ Storandt, M.⁵ Goate, A.M.⁶ Fagan, A.M.⁷ Holtzman, D.M.⁸ Mintun, M.A.⁹

14
- 34248168837
- Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: Challenges for the future
- W.E. Faison, S.K. Schultz, J. Aerssens, J. Alvidrez, R. Anand, and L.A. Farrer Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: challenges for the future Int Psychogeriatr 19 2007 539 558
- (2007) Int Psychogeriatr , vol.19 , pp. 539-558
- Faison, W.E.¹ Schultz, S.K.² Aerssens, J.³ Alvidrez, J.⁴ Anand, R.⁵ Farrer, L.A.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.